The meta-analysis of Kolibianakis found that the incidence of hospital admission for OHSS is significantly lower in GnRH antagonist cycles than in agonist cycles (OR 0.46;95% CL 0.26-0.82; P = 0.1) [16]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.